545 related articles for article (PubMed ID: 30353374)
1. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA
J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374
[TBL] [Abstract][Full Text] [Related]
2. Frequency of toxicity with chemical conversion of atrial fibrillation with dofetilide.
Brumberg G; Gera N; Pray C; Adelstein E; Barrington W; Bazaz R; Mendenhall GS; Nemec J; Voigt A; Wang NC; Schwartzman D; Saba S; Jain SK
Am J Cardiol; 2013 Aug; 112(4):505-8. PubMed ID: 23706388
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center.
Ting C; Malloy R; Knowles D
J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):438-443. PubMed ID: 32347108
[TBL] [Abstract][Full Text] [Related]
4. Dofetilide-induced long QT and torsades de pointes.
Aktas MK; Shah AH; Akiyama T
Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
[TBL] [Abstract][Full Text] [Related]
5. Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale.
Nagra BS; Ledley GS; Kantharia BK
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):191-5. PubMed ID: 16211208
[TBL] [Abstract][Full Text] [Related]
6. Dofetilide dose reductions and discontinuations in women compared with men.
Pokorney SD; Yen DC; Campbell KB; Allen LaPointe NM; Sheng S; Thomas L; Bahnson TD; Daubert JP; Picini JP; Jackson KP; Thomas KL; Al-Khatib SM
Heart Rhythm; 2018 Apr; 15(4):478-484. PubMed ID: 29605013
[TBL] [Abstract][Full Text] [Related]
7. Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies.
Jaiswal A; Goldbarg S
Indian Heart J; 2014; 66(6):640-8. PubMed ID: 25634399
[TBL] [Abstract][Full Text] [Related]
8. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
[TBL] [Abstract][Full Text] [Related]
9. Phase IV trial evaluating the effectiveness and safety of dofetilide.
Guanzon AV; Crouch MA
Ann Pharmacother; 2004; 38(7-8):1142-7. PubMed ID: 15161945
[TBL] [Abstract][Full Text] [Related]
10. Safety of Oral Dofetilide Reloading for Treatment of Atrial Arrhythmias.
Cho JH; Youn SJ; Moore JC; Kyriakakis R; Vekstein C; Militello M; Poe SM; Wolski K; Tchou PJ; Varma N; Niebauer MJ; Bhargava M; Saliba WI; Wazni OM; Lindsay BD; Wilkoff BL; Chung MK
Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29038104
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
[TBL] [Abstract][Full Text] [Related]
12. Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program.
Sugrue A; Kremen V; Qiang B; Sheldon SH; DeSimone CV; Sapir Y; Striemer BL; Brady P; Asirvatham SJ; Ackerman MJ; Friedman P; Noseworthy PA
Cardiovasc Drugs Ther; 2015; 29(5):433-41. PubMed ID: 26411977
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
Agusala K; Oesterle A; Kulkarni C; Caprio T; Subacius H; Passman R
Pacing Clin Electrophysiol; 2015 Apr; 38(4):490-8. PubMed ID: 25626340
[TBL] [Abstract][Full Text] [Related]
14. Use of dofetilide in adult patients with atrial arrhythmias and congenital heart disease: A PACES collaborative study.
El-Assaad I; Al-Kindi SG; Abraham J; Sanatani S; Bradley DJ; Halsey C; Law IH; Balaji S; Shetty I; Aziz PF
Heart Rhythm; 2016 Oct; 13(10):2034-9. PubMed ID: 27435587
[TBL] [Abstract][Full Text] [Related]
15. Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes.
Reiffel JA
Pacing Clin Electrophysiol; 2005 Aug; 28(8):877-9. PubMed ID: 16105020
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator.
Koene RJ; Menon V; Cantillon DJ; Dresing TJ; Martin DO; Kanj M; Saliba WI; Tarakji KG; Baranowski B; Hussein AA; Tchou PJ; Bhargava M; Callahan TD; Rickard JW; Niebauer MJ; Chung MK; Varma N; Wilkoff BL; Lindsay BD; Wazni OM
Circ Arrhythm Electrophysiol; 2020 Jul; 13(7):e008168. PubMed ID: 32538135
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.
Pedersen HS; Elming H; Seibaek M; Burchardt H; Brendorp B; Torp-Pedersen C; Køber L;
Am J Cardiol; 2007 Sep; 100(5):876-80. PubMed ID: 17719337
[TBL] [Abstract][Full Text] [Related]
18. Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation.
Huang HD; Waks JW; Steinhaus DA; Zimetbaum P
Heart Rhythm; 2016 Jul; 13(7):1410-7. PubMed ID: 26921760
[TBL] [Abstract][Full Text] [Related]
19. Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: a placebo-controlled, implantable cardioverter-defibrillator-based evaluation.
Mazur A; Anderson ME; Bonney S; Roden DM
J Am Coll Cardiol; 2001 Mar; 37(4):1100-5. PubMed ID: 11263615
[TBL] [Abstract][Full Text] [Related]
20. Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter.
Abraham JM; Saliba WI; Vekstein C; Lawrence D; Bhargava M; Bassiouny M; Janiszewski D; Lindsay B; Militello M; Nissen SE; Poe S; Tanaka-Esposito C; Wolski K; Wilkoff BL
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):772-6. PubMed ID: 26063741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
